BNTX (BNTX) Stock Price & Analysis
BNTX (BNTX) rose 0.85% to USD 103.76 as of September 8, 2026 at 04:20 UTC, according to Nexqual real-time market data.
BNTX last closed at USD 103.76; the session ranged USD 102.33–104.82 on volume of 626,059 shares. Market capitalization is —, with a 52-week range of USD 79.52–124 (NMS). Source: Nexqual, September 8, 2026 at 04:20 UTC.
Key Statistics (as of September 8, 2026 at 04:20 UTC)
| Price | USD 103.76 |
|---|---|
| Change | ▲ 0.85% (up) |
| Previous Close | USD 103.76 |
| Open | USD 103.76 |
| Day Range | USD 102.33 – 104.82 |
| 52-Week Range | USD 79.52 – 124 |
| Volume | 626,059 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BNTX)
Nexqual's technical model rates BNTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.8 (neutral) |
| vs SMA50 | Above (USD 96.51) |
| MACD | 2.65 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MRNA | Moderna, Inc. | USD 145.55 | ▼ 3.49% |
| NVAX | Novavax, Inc. | USD 10.22 | ▼ 0.97% |
| AZN | AstraZeneca PLC | USD 162.7 | ▲ 0.66% |
| INO | Inovio Pharmaceuticals, Inc. | USD 1.43 | ▲ 5.15% |
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 2.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:20 UTC. This page is informational and not investment advice.